media – Page 502 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Karyopharm Seeks FDA Approval for Selinexor Drug for Multiple Myeloma

The Newton Massachusetts-based company, Karyopharm Therapeutics, who developed a new class of drugs to treat multiple myeloma, is in the process of submitting a new drug application to the FDA for their selinexor drug.
- Source: MedCityNews
- 422
- July 24, 2018
cancer CAR-T therapies FDA New Approvals
Invention of Sensor to Monitor High Risk Pregnancies

A research team at the Imperial College London have developed a new sensor-based device to display fetal movements and growth in high-risk pregnancies. This is an alternative to the current self-reporting system where the mothers notice changes in fetus movements and seek medical help if needed.
- Source: The Verdict
- 624
- July 24, 2018
fetus Researches
AbbVie Investors Need not Abandon Ship yet

After watching Scott Gottlieb, M.D. of the FDA comments regarding the rebate rule changes and a warning tweet on biosimilars, AbbVie investors are bailing out. But the industry watchers claim that they don’t need to be.
- Source: FiercePharma
- 1,105
- July 24, 2018
AbbVie biopharmaceutical FDA Market Views
LabCorp won’t Confirm if SamSam is the Ransomware it’s Recovering from

LabCorp, the mammoth medical investigations company, is still recuperating from a major ransomware attack and, almost a week later, won’t reveal how the hackers got entry nor the number of servers that were hit.
- Source: Healthcare IT News
- 842
- July 24, 2018
Company Insight cybersecurity digital health
AI Code of Conduct to be Laid Down by NHS Later in 2018

In the latter part of this year, a code of conduct for the use of artificial intelligence (AI) in healthcare will be introduced by the NHS, England, announced Harpreet Sood, associate CCIO at NHS England, at The King’s Fund’s Digital Health and Care Congress 2018 on 11 July.
- Source: DigitalHealth.net
- 908
- July 24, 2018
AI NHS Policies
Survival Rates After HCV-related Liver Transplant Rise on Administration of DAAs

Investigators from Catalonia reported in the Journal of Hepatology that survival rate among hepatitis C virus (HCV) positive patients undertaking liver transplant have significantly risen after the administration of direct-acting antivirals (DAAs). DAAs also lead to a fall in the number of people with HCV requiring a liver transplant.
- Source: WorldHepatitisAlliance
- 612
- July 23, 2018
hepatitis liver transplantation Researches
AstraZeneca, Geisinger Come Together to Develop Asthma Care

Pharmaceutical giant AstraZeneca and integrated health services provider Geisinger are partnering to create an app suite, which by connecting to electronic health records (EHR) aims to upgrade asthma care.
- Source: The Verdict
- 954
- July 23, 2018
asthma Company Insight EHR mHealth
Study Unravels New Protein Complex that Repairs Broken DNA Ends

In a major breakthrough in cancer research, a team of scientists from the University of Toronto, The Institute of Cancer Research, London, The Netherlands Cancer Institute and the University of Bern have discovered how cells repair damaged strands of DNA. They revealed a brand new protein complex in cells that protect broken DNA ends and causes its repair, in their study published in Nature on Wednesday.
- Source: News Medical
- 836
- July 23, 2018
cancer DNA Researches
Stumbling into Bush Led to Severe Burns

Sunlight activates the components in the oil which leads to severe sunburns. It can become worse with heat and moisture. After her tumble, Murphy spent a few hours in the hot sun, due to which she ended up with severe burns.
- Source: LiveScience
- 557
- July 23, 2018
poison Researches
US Army Awaiting to Test MEDHUB – A Telemedicine Platform

The US Army is testing a telemedicine-based platform designed to send critical data from the field to the hospital and enabling providers to prepare for incoming patients. The connected care service is used by health systems and EMS providers for better care coordination during emergencies.
- Source: mHealth Intelligence
- 762
- July 23, 2018
New Approvals Telemedicine

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.